Influence of a glutamate carboxypeptidase II (GCPII) polymorphism (1561C→T) on plasma homocysteine, folate and vitamin B12 levels and its relationship to cardiovascular disease risk
- 1 October 2002
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 164 (2) , 269-273
- https://doi.org/10.1016/s0021-9150(02)00065-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Low Dietary Folate Intake Is Associated With an Excess Incidence of Acute Coronary EventsCirculation, 2001
- Association between plasma folate and coronary disease independent of homocysteineThe American Journal of Cardiology, 2001
- Glutamate carboxypeptidase II: a polymorphism associated with lower levels of serum folate and hyperhomocysteinemiaHuman Molecular Genetics, 2000
- Serum Total Homocysteine Concentrations in the Third National Health and Nutrition Examination Survey (1991–1994): Population Reference Ranges and Contribution of Vitamin Status to High Serum ConcentrationsAnnals of Internal Medicine, 1999
- Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine StudyThe American Journal of Clinical Nutrition, 1998
- The 677C→T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic diseaseAtherosclerosis, 1997
- Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action ProjectPublished by American Medical Association (AMA) ,1997
- The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemiaQJM: An International Journal of Medicine, 1996
- Serum folate and risk of fatal coronary heart diseaseJAMA, 1996
- A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakesPublished by American Medical Association (AMA) ,1995